BSE Rejects Kerala Ayurveda's Waiver Application for ₹5,31,000 Fine Related to Board Composition Non-Compliance

1 min read     Updated on 16 Apr 2026, 11:03 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

BSE Limited rejected Kerala Ayurveda Limited's waiver application for a ₹5,31,000 fine imposed for board composition non-compliance under Regulation 17(1) during October 2024 to June 2025. The company had filed the waiver application on September 9, 2025, but received rejection notification on April 16, 2026. Kerala Ayurveda had already paid the fine under protest on March 10, 2026, and confirmed no additional material financial implications from the penalty.

powered bylight_fuzz_icon
37906430

*this image is generated using AI for illustrative purposes only.

Kerala Ayurveda Limited has received notification from BSE Limited regarding the rejection of its waiver application for a regulatory fine of ₹5,31,000. The rejection was communicated via email on April 16, 2026, marking the end of the company's attempt to seek relief from the penalty imposed by the stock exchange.

Fine Details and Background

The fine was originally imposed by BSE on August 29, 2025, for non-compliance with board composition requirements under Regulation 17(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The violation period extended from October 1, 2024 to June 30, 2025.

Parameter: Details
Fine Amount: ₹5,31,000 (including GST @ 18%)
Original Imposition Date: August 29, 2025
Violation Period: October 1, 2024 to June 30, 2025
Regulation Violated: Regulation 17(1) of Listing Regulations

Waiver Application Timeline

Kerala Ayurveda had filed a waiver application with BSE on September 9, 2025, seeking relief from the imposed fine. However, after approximately seven months of consideration, BSE rejected the application on April 16, 2026.

Event: Date
Fine Imposed: August 29, 2025
Waiver Application Filed: September 9, 2025
Payment Made (Under Protest): March 10, 2026
Waiver Application Rejected: April 16, 2026

Financial Impact and Company Response

Despite the rejection of its waiver application, Kerala Ayurveda had already remitted the fine amount to BSE Limited under protest on March 10, 2026. The company has indicated that apart from the payment of the fine, there are no other material financial implications arising from this regulatory action.

Regulatory Compliance Disclosure

The company has fulfilled its disclosure obligations under Regulation 30 read with Schedule III of the Listing Regulations, providing detailed information as required by SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026. The disclosure includes comprehensive details about the authority involved, nature of the action, violation specifics, and financial impact assessment.

Historical Stock Returns for Kerala Ayurveda

1 Day5 Days1 Month6 Months1 Year5 Years
+1.82%+5.72%+49.17%-42.36%-26.84%+394.29%

Will Kerala Ayurveda face additional regulatory scrutiny or monitoring from BSE following this board composition violation?

How might this regulatory penalty impact Kerala Ayurveda's credit rating or ability to raise capital in the near term?

Could this rejection signal a broader tightening of BSE's stance on waiver applications for listing regulation violations?

Kerala Ayurveda Limited Clarifies Share Price Movement to BSE

1 min read     Updated on 09 Apr 2026, 05:06 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Kerala Ayurveda Limited responded to BSE's inquiry about significant share price movement on April 8, 2026, confirming full compliance with SEBI disclosure requirements. The company stated no material information was withheld and attributed price changes to market conditions, with CFO George K T reaffirming ongoing commitment to regulatory transparency.

powered bylight_fuzz_icon
37236960

*this image is generated using AI for illustrative purposes only.

Kerala ayurveda Limited has issued a clarification to BSE Limited regarding significant movement in its equity share price, responding to an inquiry dated April 8, 2026. The company's Chief Financial Officer George K T addressed the exchange's concerns through an official communication confirming regulatory compliance and transparency in disclosures.

Regulatory Compliance Confirmation

The company has affirmed its adherence to disclosure obligations under SEBI regulations. Kerala Ayurveda Limited confirmed that it has been making timely disclosures of all events and information that could impact company operations or performance, including price-sensitive information, in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Management's Position on Price Movement

The company's management has clarified its stance on the recent share price volatility through key statements:

Parameter: Company's Position
Material Information: No information withheld that may affect price or volume behavior
Price Movement Cause: Purely market-driven conditions
Management Involvement: No connection with price movement
Price-Sensitive Events: No significant events requiring investor disclosure

Ongoing Disclosure Commitments

Kerala Ayurveda Limited has reiterated its commitment to maintaining transparency with stock exchanges. The company stated it will continue making disclosures as and when any event or information requiring disclosure under Regulation 30 arises. This commitment ensures investors receive timely information about material developments that could impact their investment decisions.

Corporate Structure Details

The communication was signed by George K T, Chief Financial Officer and Designated Officer for filing, representing the company's senior management. Kerala Ayurveda Limited operates as an ISO 9001:2015 certified company with its registered office in Ernakulam, Kerala, and corporate office in Bengaluru. The company holds CIN L24233KL1992PLC006592 and trades under BSE Scrip Code 530163.

Historical Stock Returns for Kerala Ayurveda

1 Day5 Days1 Month6 Months1 Year5 Years
+1.82%+5.72%+49.17%-42.36%-26.84%+394.29%

What specific market conditions or external factors could be driving the unexplained volatility in Kerala Ayurveda's share price?

Will Kerala Ayurveda consider implementing additional investor communication measures to address future price volatility concerns?

How might this regulatory scrutiny impact Kerala Ayurveda's upcoming business expansion plans in the ayurvedic sector?

More News on Kerala Ayurveda

1 Year Returns:-26.84%